Clinical Trial Update: Clinical Course Of Disease In Participants With FA-CM

View source ↗

Summary

The clinical trial NCT06865482 by Lexeo Therapeutics is currently recruiting to study the clinical course of disease in Friedreich ataxia with cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Friedreich Ataxia

Snippet

Sponsor: Lexeo Therapeutics | Conditions: Friedreich Ataxia, Cardiomyopathy | Status: RECRUITING